CKD (CHRONIC KIDNEY DISEASE) MANAGEMENT PANEL
Chronic Kidney Disease (CKD) Management Panel includes the tests recommended for detection of most CKD complications. Such testing, combined with early treatment of the abnormalities identified, can help slow the progression of kidney damage and associated complications. For patients with CKD, KDIGO guidelines recommend addressing complications when (1) Bicarbonate is <22 mmol/L (Metabolic acidosis); (2) Hemoglobin is <13.0 g/dL in males and <12.0 g/dL in females (anemia); (3) markers of metabolic bone disease are abnormal (↑ Phosphorus, ↑ PTH, ↓ Vitamin D). A multifactorial treatment approach is required to overcome these complications.
Parameter(s) covered : 24
Report Frequency: Daily
Special Instruction: Serum sample to be drawn between 8-10 am in a fasting condition. First morning specimen of urine is preferred. Record patient's age, gender and height on test request form.
Price : ₹ 3000.00
Parameters
- A : G Ratio
- ACR Category
- Albumin
- Alkaline Phosphatase (ALP)
- Bicarbonate
- Calcium, Total
- Chloride
- CKD Classification
- Creatinine
- Creatinine, Serum
- GFR Category
- GFR Estimated
- Globulin(Calculated)
- Haemoglobin
- Height(CM)
- Phosphorus
- Potassium
- PTH-Intact
- Risk of Progression
- Sodium
- Total Protein
- Urea
- Uric Acid
- Vitamin D, 25 Hydroxy